APA (7th ed.) Citation

M, A., DS, B., NM, B., SB, B., I, C., Y, H., . . . YC, Y. (2005). Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Archives of ophthalmology (Chicago, Ill. : 1960), 123(4), 448. https://doi.org/10.1001/archopht.123.4.448

Chicago Style (17th ed.) Citation

M, Azab, et al. "Verteporfin Therapy of Subfoveal Minimally Classic Choroidal Neovascularization in Age-related Macular Degeneration: 2-year Results of a Randomized Clinical Trial." Archives of Ophthalmology (Chicago, Ill. : 1960) 123, no. 4 (2005): 448. https://doi.org/10.1001/archopht.123.4.448.

MLA (9th ed.) Citation

M, Azab, et al. "Verteporfin Therapy of Subfoveal Minimally Classic Choroidal Neovascularization in Age-related Macular Degeneration: 2-year Results of a Randomized Clinical Trial." Archives of Ophthalmology (Chicago, Ill. : 1960), vol. 123, no. 4, 2005, p. 448, https://doi.org/10.1001/archopht.123.4.448.